U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C19H29N2O5S.Ca
Molecular Weight 835.096
Optical Activity UNSPECIFIED
Defined Stereocenters 6 / 6
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MOVELTIPRIL CALCIUM

SMILES

[Ca++].C[C@H](CSC(=O)[C@@H](C)NC(=O)C1CCCCC1)C(=O)N2CCC[C@H]2C([O-])=O.C[C@H](CSC(=O)[C@@H](C)NC(=O)C3CCCCC3)C(=O)N4CCC[C@H]4C([O-])=O

InChI

InChIKey=CUZMQPZYCDIHQL-VCTVXEGHSA-L
InChI=1S/2C19H30N2O5S.Ca/c2*1-12(17(23)21-10-6-9-15(21)18(24)25)11-27-19(26)13(2)20-16(22)14-7-4-3-5-8-14;/h2*12-15H,3-11H2,1-2H3,(H,20,22)(H,24,25);/q;;+2/p-2/t2*12-,13-,15+;/m11./s1

HIDE SMILES / InChI

Molecular Formula Ca
Molecular Weight 40.078
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C19H29N2O5S
Molecular Weight 397.509
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Moveltipril is a captopril derivative patented by Japanese pharmaceutical company Chugai Pharmaceutical Co., Ltd. as an angiotensin-converting enzyme inhibitor, that decreases systemic blood pressure more slowly and persistently than captopril. Moveltipril is partially metabolized to captopril by hydrolysis, predominantly in the liver. In preclinical studies administration of Moveltipril to the anesthetized dogs produced a gradual and dose-dependent decline in aortic pressure associated with no marked changes in coronary blood flow, heart rate. Both Moveltipril and captopril inhibited selectively the pressor response to angiotensin I in a dose-related manner.

Approval Year

PubMed

PubMed

TitleDatePubMed
Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
1986 Mar
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Sources: Naika Hokan (1984), 31, (5), 175-8.
40 mg
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 20:17:55 GMT 2023
Edited
by admin
on Fri Dec 15 20:17:55 GMT 2023
Record UNII
SB44S25HE5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MOVELTIPRIL CALCIUM
Common Name English
MOVELTIPRIL CALCIUM SALT
MI  
Common Name English
ALTIOPRIL CALCIUM
Common Name English
MC-838
Code English
MOVELTIPRIL CALCIUM SALT [MI]
Common Name English
MOVELTIPRIL CALCIUM [JAN]
Common Name English
L-PROLINE, N-(CYCLOHEXYLCARBONYL)-D-ALANYL-(2S)-3-MERCAPTO-2-METHYLPROPANOYL-, CALCIUM SALT (2:1)
Systematic Name English
LOWPRES
Brand Name English
Code System Code Type Description
PUBCHEM
6917881
Created by admin on Fri Dec 15 20:17:55 GMT 2023 , Edited by admin on Fri Dec 15 20:17:55 GMT 2023
PRIMARY
FDA UNII
SB44S25HE5
Created by admin on Fri Dec 15 20:17:55 GMT 2023 , Edited by admin on Fri Dec 15 20:17:55 GMT 2023
PRIMARY
CAS
85921-53-5
Created by admin on Fri Dec 15 20:17:55 GMT 2023 , Edited by admin on Fri Dec 15 20:17:55 GMT 2023
PRIMARY
MERCK INDEX
m7641
Created by admin on Fri Dec 15 20:17:55 GMT 2023 , Edited by admin on Fri Dec 15 20:17:55 GMT 2023
PRIMARY Merck Index
Related Record Type Details
PARENT -> SALT/SOLVATE